Ed has been at NEA since 2008 and is currently a Partner on the healthcare team focused on biotechnology and specialty pharmaceuticals investments. Prior to joining NEA, Ed served as EVP of Corporate Development and Venture at MedImmune, where he helped execute the sale of the company to AstraZeneca in 2007. Before joining MedImmune, he was VP of Marketing and Corporate Licensing and Acquisitions at Inhale Therapeutic Systems. Ed also spent 15 years at Glaxo Wellcome (now GSK), where he held sales and marketing positions.